Latest News

Piramal to expand in API manufacturing capabilities with $55m

Piramal Pharma Solutions (PPS) is set to invest $55m across its production sites in North America and Asia in order to expand its active pharmaceutical ingredients (API) manufacturing...

Piramal to expand in API manufacturing capabilities with $55m

Avara Pharmaceutical buys AstraZeneca’s Reims solid dosage facility

Avara Pharmaceutical buys AstraZeneca’s Reims solid dosage facility

GSK’s Benlysta receives Japanese MHLW approval for systemic lupus erythematosus

GSK’s human monoclonal antibody Benlysta (belimumab) has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to treat adult patients with systemic lupus...

GSK’s Benlysta receives Japanese MHLW approval for systemic lupus erythematosus

EC grants marketing authorisation for Sanofi and Regeneron’s Dupixent for AD

EC grants marketing authorisation for Sanofi and Regeneron’s Dupixent for AD

Recipharm and Roche sign agreement to manufacture solid dose products

Swedish pharmaceutical company Recipharm has signed a long-term manufacturing agreement with Roche to produce a wide range of solid dose...

Recipharm and Roche sign agreement to manufacture solid dose products

J&J completes Actelion acquisition for $30bn

Johnson & Johnson (J&J) has completed the acquisition of Actelion Pharmaceuticals for approximately $30bn in an all-cash transaction through its Swiss subsidiary Janssen...

J&J completes Actelion acquisition for $30bn

Integral Molecular begins immuno-oncology therapeutic targets discovery

Integral Molecular begins immuno-oncology therapeutic targets discovery

Boehringer opens biopharmaceutical manufacturing facility in China

Boehringer opens biopharmaceutical manufacturing facility in China

GSK invests $139m to increase Benlysta (belimumab) production capacity

GSK invests $139m to increase Benlysta (belimumab) production capacity

FDA grants Breakthrough Therapy designation to Novartis CTL019 for DLBCL

FDA grants Breakthrough Therapy designation to Novartis CTL019 for DLBCL

CBMG and GE to co-develop control processes in CAR-T and stem-cell manufacturing

CBMG and GE to co-develop control processes in CAR-T and stem-cell manufacturing

Sweden’s Sobi debates sale of Partner Products business area

Sweden’s Sobi debates sale of Partner Products business area

Patheon acquires Roche’s manufacturing facility in South Carolina, US

Patheon acquires Roche’s manufacturing facility in South Carolina, US

Victorian Government receives funding for thunderstorm asthma research

Victorian Government receives funding for thunderstorm asthma research

Mylan wins court ruling for Copaxone 40mg/mL patents

Global generic and specialist pharmaceuticals company Mylan has won a US District Court Ruling with regards to its Copaxone 40mg/mL...

Mylan wins court ruling for Copaxone 40mg/mL patents

Onxeo and Institut Curie to study benefits of combining radiotherapy, DNA repair inhibitors and immunotherapy

French bio-pharmaceutical company Onxeo and the Institut Curie have collaborated to launch a series of studies aimed to investigate the benefits of combining radiotherapy, DNA repair inhibitors...

Onxeo and Institut Curie to study benefits of combining radiotherapy, DNA repair inhibitors and immunotherapy

Merus closes global strategic research collaboration with Incyte

Netherlands-based Immuno-oncology company Merus has closed its previously announced global strategic research collaboration with...

Merus closes global strategic research collaboration with Incyte

Domain Therapeutics signs GPCR licensing agreement with Alkermes

Biopharmaceutical company Domain Therapeutics has signed a licensing agreement for its G-protein-coupled receptors (GPCR) BioSens-All technology with Ireland-based Alkermes....

Domain Therapeutics signs GPCR licensing agreement with Alkermes

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug

Melbourne scientists develop first therapeutic dental vaccine

Melbourne scientists develop first therapeutic dental vaccine

Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany

Takeda Pharmaceuticals has announced plans to invest more than €100m to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany....

Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany
cachename:Newscachekey:rd-137342983_-954009584_rd-1665407042_1857678299_rd-488908060_1460672566_ap1460672566_1857678299_1613048906